Bionano Genomics (BNGO) Other Operating Expenses (2017 - 2026)

Bionano Genomics has disclosed Other Operating Expenses across 7 years of filings, most recently posting -$700000.0 for Q1 2026.

• Other Operating Expenses for Q1 2026 came in at -$700000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$700000.0 (down 103.19% YoY), and the FY2025 annual result was -$2.6 million, down 110.44% from the prior year.
• Other Operating Expenses came in at -$700000.0 for Q1 2026 at Bionano Genomics, roughly flat from -$700000.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $77.3 million in Q3 2023 to a low of -$700000.0 in Q1 2025.
• The 4-year median for Other Operating Expenses is $978000.0 (2023), against an average of $13.0 million.
• Across the five-year window, Other Operating Expenses tumbled 113.78% in 2025 and changed 0.0% in 2026, its largest moves.
• Bionano Genomics' Other Operating Expenses stood at $741000.0 in 2023, then plunged by 81.38% to $138000.0 in 2024, then plunged by 607.25% to -$700000.0 in 2025, then changed by 0.0% to -$700000.0 in 2026.
• The last three Other Operating Expenses figures came in at -$700000.0 (Q1 2026), -$700000.0 (Q1 2025), and $138000.0 (Q4 2024), per Business Quant data.